$ATNM @ActiniumPharma  $KIADF Cell therapies inks license deal with Sanofi valued as high as €875M. ATNM could get licensing in 2H $jazz $jnj $nvs $sny $azn $abbv $amgn $gild $biib $tgtx $tril $cvm $lly $pfe $tgtx $trill #pennystocks $cydy #OTCStocks  https://t.co/GkHbXiFpxe